Synbiotic Compound to Reduce Symptoms of Schizophrenia

Clinical trial NCT04226898 · RECRUITING

Trial details

NCT number: NCT04226898
Sponsor: Sheppard Pratt Health System
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2022-02-21
Primary completion: 2027-03-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.